Cutler Group LP Royalty Pharma PLC Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$37.53 - $44.22 $93,825 - $110,550	-2,500 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$37.46 - $42.44 $318,410 - $360,740	-8,500 Reduced 77.27%	2,500 $2,000
Q3 2021 Oct 26, 2021	BUY	$36.14 - $42.24 $354,172 - $413,952	9,800 Added 816.67%	11,000 $4,000
Q2 2021 Jul 19, 2021	SELL	$39.85 - $46.63 $47,820 - $55,956	-1,200 Reduced 50.0%	1,200 $1,000
Q1 2021 Apr 26, 2021	SELL	$42.34 - $52.82 $131,254 - $163,742	-3,100 Reduced 56.36%	2,400 $7,000
Q4 2020 Jan 21, 2021	SELL	$36.12 - $50.05 $10,836 - $15,015	-300 Reduced 5.17%	5,500 $76,000
Q3 2020 Oct 27, 2020	BUY	$38.56 - $48.36 $204,368 - $256,308	5,300 Added 1060.0%	5,800 $45,000
Q2 2020 Jul 22, 2020	BUY	$44.5 - $52.11 $22,250 - $26,055	500 New	500 $1,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.